semaglutide cardiac protection Cardiovascular outcomes of and tirzepatide for patients with type 2 diabetes in clinical practice New evidence shows tirzepatide and
Description
Avg weight loss (72 weeks): ~15% (SURMOUNT-1) 10 mg Weeks 1316 The most common maintenance dose
Though approximately 1.6% of Americans currently take some form of this medication, studies suggest that over 53% of the US population would be eligible for a semaglutide prescription
Drinking most of your water earlier in the day and tapering intake toward evening reduces nighttime bathroom visits
While research on semaglutide and sexual function is limited, studies show weight loss and improved metabolic health can lead to better sexual function, particularly in people with obesity
